AAIPharma sells development services unit

July 27, 2009
Manufacturing and Production, Research and Development AAI Pharma

US pharmaceutical services firm AAIPharma has sold its drug development division to a private equity firm in another example of …

Manufacturing news in brief

July 27, 2009
Manufacturing and Production GSK

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Takeda, Merrion Pharma, Cambridge Major, Dendreon and GlaxoSmithKline, …

Sales strategies for a changing environment

July 24, 2009
Sales and Marketing market access, sales, strategy

Over the last two years the UK pharma industry's established product sales strategies have begun to change. The industry's primary …

Nextpharma gets nod for Belgian manufacturing unit

July 24, 2009
Manufacturing and Production Next Pharma

UK contract development and manufacturing company NextPharma has won a preliminary green light from the authorities in Belgium for its …

Merck makes progress on vaccines supply issues

July 24, 2009
Manufacturing and Production Merck

Merck & Co's new manufacturing facility in Durham, North Carolina, is on schedule to start production of vaccines in the …

BMS buys Medarex for $2.1 billion

July 24, 2009
Research and Development, Sales and Marketing BMS, MA, Medarex

Bristol-Myers Squibb is to spend $2.1 billion in buying Medarex, the human antibody drug discovery specialists. Princeton-based Medarex is best …

Generic losses outweigh pandemic pluses for GSK

July 23, 2009
Sales and Marketing GSK

GlaxoSmithKline has reported a 2% fall in sales for the second quarter as growing generic competition in the US bites. …

Lupus drug shows surprise phase III success

July 23, 2009
Research and Development, Sales and Marketing Benlysta, GSK, HGS, Lupus

 GSK and Human Genome Sciences’ lupus drug Benlysta has surprised analysts by showing unexpectedly positive results in a pivotal late-stage …

Profits slump at Lonza as business is realigned

July 23, 2009
Manufacturing and Production Lonza

Swiss chemical and contract manufacturing group Lonza saw a slump in sales and profits in the first half of the …

Kennedy calls for overhaul of NICE processes

July 23, 2009
Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …

Advertising: be brief, be bold

July 22, 2009
Sales and Marketing Pfizer, advertising, branding

In the pharma industry, do we believe that the gap between what our businesses promise and what results our businesses …

NICE approves MabThera for leukaemia

July 22, 2009
Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …

Pharmaceutical manufacturing: news in brief

July 22, 2009
Manufacturing and Production GW

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from GW and Viva Biopharm, GMP problems at an …

Tracleer expansion fuels Actelion growth

July 22, 2009
Sales and Marketing Actelion, Tracleer

Sales of pulmonary arterial hypertension treatment Tracleer are continuing to grow worldwide, helping to boost the fortunes of Actelion. The …

PharmaTelevision launches new premium content service

July 21, 2009
Medical Communications Pharma TV, digi

PharmaTelevision, an online TV channel dedicated to coverage of the pharmaceutical, biotech and related industries is to launch a new …

Phase Forward buys Covance unit for $10m

July 21, 2009
Research and Development CRO, Phase Forward

US clinical data management specialist Phase Forward is planning to get bigger in interactive response technologies (IRT) via a $10 …

Nycomed to invest in Russian manufacturing facility

July 21, 2009
Manufacturing and Production Nycomed, Russia

Swiss pharmaceutical company Nycomed is already a big player in the Russian drug market, and looks set to consolidate that …

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009
Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …

The Gateway to Local Adoption Series

Latest content